The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Predictive importance of ulceration on the efficacy of adjuvant interferon-a (IFN): An individual patient data (IPD) meta-analysis of 15 randomized trials in more than 7,500 melanoma patients (pts).
Stefan Suciu
No relevant relationships to disclose
Natalie Ives
No relevant relationships to disclose
Alexander M. Eggermont
No relevant relationships to disclose
John M. Kirkwood
No relevant relationships to disclose
Paul Lorigan
No relevant relationships to disclose
Svetomir Markovic
No relevant relationships to disclose
Claus Garbe
Consultant or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Philogen; Roche
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Philogen; Roche
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; Roche
Keith Wheatley
No relevant relationships to disclose